Compare Illumina, Inc. (ILMN) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Symbotic Inc — how do they compare? Illumina, Inc. trades at $189.41 (market cap $27.94B), while Symbotic Inc trades at $42.4 (market cap $5.19B). The key difference: Illumina, Inc. is far larger — about 5.4× Symbotic Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | SYM | |
|---|---|---|
Market Cap | $27.94B | $5.19B |
Sector | Health | Technology |
52-Week High | $194.33 | $87.30 |
52-Week Low | $91.00 | $38.57 |
Enterprise Value | $29.33B | $3.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Symbotic (SYM) trades at $40.83, down 1.02% recently, with a bearish technical signal and key support at $40. The company reported revenue of $2.25 billion in 2025 but a net loss of $16.94 million, though gross margins improved to 20.43%. Recent news highlights its acquisition of ARMS Innovations and upcoming Q3 2026 earnings on August 5, 2026, amid growing interest in warehouse automation.
Analyst consensus is bullish with a $57.50 price target, but risks include persistent net losses, high EV/EBITDA of 219.3, and competitive pressures. The stock offers growth potential from AI-driven warehouse automation demand, yet profitability challenges and market volatility pose significant headwinds for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
